PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Biopharma Business Check

High-Risk Marketing Violations Draw Scrutiny

Steadying the Path of Good Science

Advertisement
Advertisement
Biotech
Southeast Biotech: Rising Tall in the Valley
Michelle Maskaly examines the booming life sciences scene in southeast Virginia and Raleigh-Durham and Winston-Salem, North Carolina—and the region's advantages in location, talent, and funding compared to the more glamour spots up north
/Read more/
Advertisement
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
Biotech
Trust–Biotech's Hidden Advantage
Bruce Hayes discusses how companies can build trust now to cultivate corporate reputations that build business /Read more/
Advertisement
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Learn more
Special Feature
Pharm Exec's 2019 Pipeline Report
This year's Pipeline Report sees CAR-T therapy eyeing new territory, cannabis-based agents targeting CNS and rare genetic disorders, the advancement of non-opioid alternatives, and the untangling of the path to market for biosimilars
/Read more/
Advertisement
Disaster Recovery in Pharma with Oracle Cloud
Data is the lifeblood of an enterprise. Oracle Cloud Infrastructure for Enterprise provides optimized solutions for disaster recovery, data protection, and an ability to more effectively access critical data, for Oracle and non-Oracle workloads.
Watch the video
ADVERTISEMENT Advertisement
Calendar
/ November 28–29: Compliant Patient Support Programs Summit /
Chicago, IL
/ December 3–4: Digital Therapeutics /
New York, NY
/ December 4–5: Bio/Pharma Compliance Congress on Non-Promotional Activities /
Philadelphia, PA
/ December 4–5: Managed Markets Compliance Congress 2018 /
Philadelphia, PA
/ December 5–6: Supporting the Patient Experience /
Philadelphia, PA
/ December 12: Specialty Product Data Strategies /
Philadelphia, PA
/ January 22–23, 2019: 14th Biosimilars Summit /
Alexandria, VA
/ January 23–24, 2019: Data Analytics and Decisions /
Philadelphia, PA
/ March 4–6, 2019: 20th Annual Patient Assistance and Access Programs – PAP 2019 /
Baltimore, MD
Advertisement
Special Feature
Pipeline Drill-Down: Perspectives on Alzheimer's, Opioids, and Cannabis
Analysts from Pharma Intelligence take a deeper dive into these three pivotal areas of R&D today–the crisis points and progress
/Read More/
Advertisement
Patient Assistance Centers of Excellence: The Next Generation of Brand Support
On Demand
Learn More
Legal
Patent Protection for Cannabis?
Amid a still-difficult environment for enforcing cannabis-related patents, Eric Furman and Ari Feinstein explore the types of patent protection available for cannabis-based therapies and inventions
/Read More/
Advertisement
Bringing Intelligence to Drug Discovery—The Importance of Contextual Information at All Levels
On Demand
Learn More
Opinion
Stunted Innovation in Drug Development?
Data shows cultural gaps and highlights a C-level fix, writes Meghan Oates-Zalesky
/Read More/
Advertisement
Seizing Opportunities in Japan, the Second Largest Innovation-Driven Pharmaceutical Market
On Demand
Learn More

Industry update
// ChromaDex Corp. (Los Angeles,CA) announced it has appointed Matthew Roberts as Chief Scientific Officer and Senior Vice President of Innovation, effective immediately. // The International Biomedical Research Alliance (Bethesda, MD) announced that Tom Heyman is joining the Alliance's Board of Directors. Mr. Heyman is president of the Johnson & Johnson Development Corporation (JJDC) and leads the J&J Venture Capital Group. // Bioanalytical Systems (West Lafayette, IN) appointed John E. Sagartz, DVM, Ph.D, DACVP, as Chief Strategy Officer. // BioDelivery Sciences International (Raleigh, NC) appointed James Vollins as General Counsel and member of its Executive Leadership Team Mr. Vollins will also serve as the company's Chief Compliance Officer and Corporate Secretary.
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com